Kura Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kura Oncology and other ETFs, options, and stocks.

About KURA

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias.

CEO

Troy E. Wilson

CEOTroy E. Wilson

Employees

142

Employees142

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2014

Founded2014

Employees

142

Employees142

KURA Key Statistics

Market cap

1.34B

Market cap1.34B

Price-Earnings ratio

-8.63

Price-Earnings ratio-8.63

Dividend yield

—

Dividend yield—

Average volume

673.06K

Average volume673.06K

High today

$18.05

High today$18.05

Low today

$17.54

Low today$17.54

Open price

$17.97

Open price$17.97

Volume

1.54M

Volume1.54M

52 Week high

$24.17

52 Week high$24.17

52 Week low

$7.41

52 Week low$7.41

Analyst ratings

93%

of 14 ratings

Buy

92.9%

Hold

7.1%

Sell